Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.304 $0.440 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $0.304 $0.532
52 weeks $0.250 $1.09

Historical Clene Inc. prices

Date Open High Low Close Volume
Jan 22, 2024 $0.480 $0.480 $0.421 $0.468 416 338
Jan 19, 2024 $0.511 $0.511 $0.430 $0.460 385 293
Jan 18, 2024 $0.460 $0.492 $0.431 $0.450 504 285
Jan 17, 2024 $0.520 $0.545 $0.472 $0.486 1 143 590
Jan 16, 2024 $0.480 $0.510 $0.412 $0.510 1 189 905
Jan 12, 2024 $0.444 $0.515 $0.432 $0.480 1 767 603
Jan 11, 2024 $0.400 $0.437 $0.390 $0.432 712 137
Jan 10, 2024 $0.409 $0.410 $0.373 $0.400 847 986
Jan 09, 2024 $0.350 $0.430 $0.350 $0.419 3 065 314
Jan 08, 2024 $0.299 $0.370 $0.295 $0.354 3 437 568
Jan 05, 2024 $0.299 $0.300 $0.276 $0.290 780 691
Jan 04, 2024 $0.290 $0.292 $0.272 $0.279 629 015
Jan 03, 2024 $0.298 $0.300 $0.272 $0.288 969 975
Jan 02, 2024 $0.299 $0.305 $0.285 $0.294 1 342 655
Dec 29, 2023 $0.291 $0.300 $0.289 $0.297 2 802 723
Dec 28, 2023 $0.270 $0.305 $0.265 $0.280 2 514 565
Dec 27, 2023 $0.279 $0.287 $0.250 $0.260 3 050 300
Dec 26, 2023 $0.305 $0.316 $0.270 $0.276 2 351 503
Dec 22, 2023 $0.315 $0.340 $0.286 $0.290 2 722 101
Dec 21, 2023 $0.338 $0.350 $0.276 $0.315 8 812 370
Dec 20, 2023 $0.600 $0.600 $0.503 $0.515 560 180
Dec 19, 2023 $0.490 $0.595 $0.490 $0.545 1 179 939
Dec 18, 2023 $0.430 $0.500 $0.421 $0.499 693 257
Dec 15, 2023 $0.420 $0.470 $0.401 $0.420 757 466
Dec 14, 2023 $0.414 $0.458 $0.386 $0.420 1 004 134
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT